Skip to main content
Donate
Login
Celebrate IASLC's 50th Anniversary
Celebrate IASLC's 50th Anniversary
History
Support The Mission
Support The Mission
Partners for Thoracic Cancer Care
Legacy Society
IASLC Global Member Survey on Inclusivity
Learn About Us
Learn About Us
Strategic Plan
Board of Directors
Committees
Awards
Staff
Contact
Search
Donate
Login
Conferences & Webinars
Conferences & Webinars
Upcoming Conferences & Webinars
Past Conferences & Webinars
WCLC 2024
Research & Education
Research & Education
Scientific Projects
Scientific Projects
IASLC Staging Project: Lung Cancer, Thymic Tumors, and Mesothelioma
IASLC Global Survey on Biomarker Testing in Lung Cancer 2024 Update
IASLC Neoadjuvant Therapy in Lung Cancers Initiatives
IASLC Atlas of Molecular Testing for Targeted Therapy in Lung Cancer
ELIC
Past IASLC Scientific Projects
Lung Cancer 360
Journals
Journals
Journal of Thoracic Oncology
JTO Clinical and Research Reports (JTO CRR)
IASLC Reviewer Workshop
Early-Career Opportunities
Early-Career Opportunities
IASLC Academy
Publications, Resources & Guidelines
News
News
ILCN
Press Releases
Lung Cancer Considered Podcast
Membership
Membership
Become a Member
Renew Your Membership
IASLC Partnerships
Patient Advocacy
Patient Advocacy
STARS
Lung Cancer Awareness Month 2023 Highlights
Foundation
Foundation
Donor Recognition
Research Grant Program
Grant Recipient Spotlights
Research Grant Recipients
Search
Fulltext search
Fulltext search
Search
Displaying 349 - 360 items out of 1999 results
ILCN article
The IASLC Language Guide: A Lexicon of Healing for Lung Cancer and Beyond
ILCN article
China’s Domestic PD-1/PD-L1 Inhibitors Demanding Global Attention
ILCN article
Surgical Outcomes of CheckMate816 Support Use of Neoadjuvant Nivolumab Plus Chemotherapy for NSCLC
ILCN article
VIOLET Data Establishes VATS as Standard for Early-Stage Resectable NSCLC
ILCN article
3D Model of Lung Nodules Reduces Anxiety for Patients While Helping Them Understand Their Cancer Risk
ILCN article
First Comprehensive Genomic Profiling Assay Approved for Use with Brigatinib, ALK-positive NSCLC
ILCN article
High-Dose Once-Daily Thoracic Radiotherapy Did Not Improve OS in Limited Stage SCLC
ILCN article
Single Institution’s Experience: SABR Shows Outstanding OS vs. VATS in Patients with Early-Stage NSCLC
ILCN article
Awareness-raising Bike Ride in The Netherlands Connected Hospitals, Patients
ILCN article
Understanding and Targeting SCLC
ILCN article
KRAS: Old Target, New Hope
ILCN article
Prophylactic Radiotherapy: A Case for Patients at High Risk of Brain Metastases
Pagination
First
First page
‹
Previous page
…
26
27
28
29
30
31
32
33
34
…
›
Next page
Last
Last page